Alumis, Inc. (ALMS)
9.265
-0.64
(-6.41%)
USD |
NASDAQ |
Sep 11, 13:44
Alumis Gross Profit (TTM) : 3.87M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.87M |
| March 31, 2026 | 4.878M |
| December 31, 2025 | 20.55M |
| September 30, 2025 | 18.67M |
| June 30, 2025 | 16.71M |
| March 31, 2025 | 14.15M |
| December 31, 2024 | -3.152M |
| Date | Value |
|---|---|
| September 30, 2024 | -3.058M |
| June 30, 2024 | -2.562M |
| March 31, 2024 | -1.922M |
| December 31, 2023 | -1.284M |
| September 30, 2023 | -0.558M |
| June 30, 2023 | -0.24M |
| March 31, 2023 | -0.12M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Johnson & Johnson | 66.63B |
| Corcept Therapeutics, Inc. | 816.73M |
| Aclaris Therapeutics, Inc. | 1.06M |
| Crinetics Pharmaceuticals, Inc. | 36.49M |
| ANI Pharmaceuticals, Inc. | 505.18M |